Clinical Research Directory
Browse clinical research sites, groups, and studies.
Native Coronary Artery Instead of SAphenous Vein Graft Intervention for Treatment of Significant Saphenous Vein Graft Lesions
Sponsor: Minneapolis Heart Institute Foundation
Summary
The primary study objective of the NASA registry is to evaluate the 12-month incidence of target vessel failure (TVF) in patients who present with saphenous vein graft (SVG) lesions and undergo percutaneous coronary intervention (PCI) of the corresponding native coronary artery.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
99
Start Date
2021-11-21
Completion Date
2030-01
Last Updated
2025-01-27
Healthy Volunteers
No
Interventions
Percutaneous coronary intervention of the native coronary artery with Synergy
This is a registry study that will enroll patients with a 50-100% de novo SVG lesion and treated with percutaneous coronary intervention of the corresponding native coronary artery using a SYNERGY stent.
Locations (2)
Henry Ford Health System
Detroit, Michigan, United States
Minneapolis Heart Institute Foundation
Minneapolis, Minnesota, United States